United Therapeutics UTHR reported weaker-than-expected third-quarter earnings.
United Therapeutics posted its quarterly net income at $62.7 million, or $1.17 per share, down from $78.1 million, or $1.46 per share, in the year-ago period.
Its total revenue climbed 25% to $302.2 million. However, analysts were estimating a profit of $1.59 per share on sales of $279 million.
Its selling, general and administrative expenses rose 37% in the quarter.
United Therapeutics shares closed at $83.39 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in